Heart failure: beta-blockers reduce all-cause mortality in patients with preserved ejection fraction

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • In patients with heart failure and a left ventricular (LV) ejection fraction ≥40%, beta-blockers reduced all-cause and cardiovascular mortality by 22% and 25%, respectively.
  • Angiotensin-converting-enzyme (ACE) inhibitor, angiotensin receptor blocker (ARB) and mineralocorticoid ...